William Hagopian

20.8k total citations · 4 hit papers
163 papers, 9.8k citations indexed

About

William Hagopian is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, William Hagopian has authored 163 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Genetics, 115 papers in Surgery and 101 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in William Hagopian's work include Diabetes and associated disorders (138 papers), Pancreatic function and diabetes (111 papers) and Diabetes Management and Research (92 papers). William Hagopian is often cited by papers focused on Diabetes and associated disorders (138 papers), Pancreatic function and diabetes (111 papers) and Diabetes Management and Research (92 papers). William Hagopian collaborates with scholars based in United States, Sweden and Finland. William Hagopian's co-authors include Åke Lernmark, Kevan C. Herold, Jeffrey P. Krischer, Beena Akolkar, Jin‐Xiong She, Stephen E. Gitelman, Jeffrey A. Bluestone, Jorma Toppari, David M. Harlan and David Donaldson and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

William Hagopian

159 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus

2002 903 citations Kevan C. Herold, William Hagopian et al. profile →
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study

2015 295 citations Jeffrey P. Krischer, Kristian Lynch et al. Diabetologia profile →
Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis

2019 206 citations Seth A. Sharp, Stephen S. Rich et al. Diabetes Care profile →
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

2022 117 citations Emily K. Sims, Rachel Besser et al. Diabetes profile →

Peers

Countries citing papers authored by William Hagopian

Since Specialization

Citations

This map shows the geographic impact of William Hagopian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Hagopian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Hagopian more than expected).

Fields of papers citing papers by William Hagopian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Hagopian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Hagopian. The network helps show where William Hagopian may publish in the future.

Co-authorship network of co-authors of William Hagopian

This figure shows the co-authorship network connecting the top 25 collaborators of William Hagopian. A scholar is included among the top collaborators of William Hagopian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Hagopian. William Hagopian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Islet autoantibody frequency in relatives of children with type 1 diabetes who have a type 2 diabetes diagnosis 2024 ·Diabetic Medicine ·(unknown), Claire Williams, (unknown), (unknown), (unknown), Richard A. Oram, William Hagopian, Kathleen M. Gillespie, Anna E. Long	1
2	The Influence of Pubertal Development on Autoantibody Appearance and Progression to Type 1 Diabetes in the TEDDY Study 2024 ·Journal of the Endocrine Society ·Katharina Warncke, Roy Tamura, Desmond Schatz, Riitta Veijola, Andrea K. Steck, Beena Akolkar, William Hagopian, Jeffrey P. Krischer, Åke Lernmark, Marian Rewers, Jorma Toppari, Richard McIndoe, Anette‐G. Ziegler, Kendra Vehik, Michael J. Haller, Helena Elding Larsson	0
3	Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective breakdown → 2022 ·Diabetes ·Emily K. Sims, Rachel Besser, Colin Dayan, Cristy Geno Rasmussen, Carla J. Greenbaum, Kurt Griffin, William Hagopian, Mikael Knip, Anna E. Long, Frank B. Martin, Chantal Mathieu, Marian Rewers, Andrea K. Steck, John M. Wentworth, Stephen S. Rich, Olga Kordonouri, Anette‐Gabriele Ziegler, Kevan C. Herold, (unknown)	117
4	Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes 2022 ·Diabetes ·Bum Chul Kwon, Peter Achenbach, Vibha Anand, Brigitte I. Frohnert, William Hagopian, Jianying Hu, Eileen Koski, Åke Lernmark, Olivia Lou, Frank B. Martin, Kenney Ng, Jorma Toppari, Riitta Veijola	2
5	Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories 2022 ·Nature Communications ·Bum Chul Kwon, Vibha Anand, Peter Achenbach, Jessica L. Dunne, William Hagopian, Jianying Hu, Eileen Koski, Åke Lernmark, Markus Lundgren, Kenney Ng, Jorma Toppari, Riitta Veijola, Brigitte I. Frohnert, (unknown)	22
6	Temporal changes in gastrointestinal fungi and the risk of autoimmunity during early childhood: the TEDDY study 2022 ·Nature Communications ·Thomas A. Auchtung, Christopher J. Stewart, Daniel P. Smith, Eric W. Triplett, Daniel Agardh, William Hagopian, Anette G. Ziegler, Marian Rewers, Jin‐Xiong She, Jorma Toppari, Åke Lernmark, Beena Akolkar, Jeffrey P. Krischer, Kendra Vehik, Jennifer M. Auchtung, Nadim J. Ajami, Joseph F. Petrosino	32
7	Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes 2021 ·Diabetes Care ·Angus G. Jones, Timothy J. McDonald, Beverley M. Shields, William Hagopian, Andrew T. Hattersley	56
8	First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child’s genetic risk 2021 ·Diabetologia ·Suzanne Bennett Johnson, Kristian Lynch, Roswith Roth, Markus Lundgren, Hemang Parikh, Beena Akolkar, William Hagopian, Jeffrey P. Krischer, Marian Rewers, Jin‐Xiong She, Jorma Toppari, Anette G. Ziegler, Åke Lernmark, (unknown)	7
9	Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children 2021 ·Diabetes Care ·Kenney Ng, Harry Stavropoulos, Vibha Anand, Riitta Veijola, Jorma Toppari, Marlena Maziarz, Markus Lundgren, (unknown), Brigitte I. Frohnert, Frank B. Martin, William Hagopian, Peter Achenbach	9
10	DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life 2021 ·Diabetologia ·Nicholas J. Thomas, John Dennis, Seth A. Sharp, (unknown), Shivani Misra, Helen C. Walkey, Desmond G. Johnston, Nick Oliver, William Hagopian, Michael N. Weedon, Kashyap Patel, Richard A. Oram	17
11	Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study 2021 ·Diabetologia ·Jeffrey P. Krischer, Xiang Liu, Åke Lernmark, William Hagopian, Marian Rewers, Jin‐Xiong She, Jorma Toppari, Anette‐G. Ziegler, Beena Akolkar, (unknown)	22
12	Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression 2021 ·Science Translational Medicine ·(unknown), (unknown), Åke Lernmark, Ezio Bonifacio, William Hagopian, Marian Rewers, Jin‐Xiong She, Jorma Toppari, Hemang Parikh, Kenneth G. C. Smith, Anette‐G. Ziegler, Beena Akolkar, Jeffrey P. Krischer, Eoin McKinney	29
13	A single nucleotide polymorphism genetic risk score to aid diagnosis of coeliac disease: a pilot study in clinical care 2020 ·Alimentary Pharmacology & Therapeutics ·Seth A. Sharp, Samuel E. Jones, (unknown), Michael N. Weedon, Anne Halpin, Andrew R. Wood, Robin N. Beaumont, (unknown), David A. van Heel, Patricia Campbell, William Hagopian, Justine Turner, Richard A. Oram	14
14	Early Probiotic Supplementation and the Risk of Celiac Disease in Children at Genetic Risk 2019 ·Nutrients ·Ulla Uusitalo, Carin Andrén Aronsson, Xiang Liu, Kalle Kurppa, Jimin Yang, Edwin Liu, Jennifer Skidmore, Christiane Winkler, Marian Rewers, William Hagopian, Jin‐Xiong She, Jorma Toppari, Anette‐G. Ziegler, Beena Akolkar, Jill M. Norris, Suvi Μ. Virtanen, Jeffrey P. Krischer, Daniel Agardh, (unknown)	21
15	Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort 2018 ·Journal of Autoimmunity ·Ashok Sharma, Xiang Liu, David Hadley, William Hagopian, Wei‐Min Chen, Suna Önengüt-Gümüşcü, Carina Törn, Andrea K. Steck, Brigitte I. Frohnert, Marian Rewers, Anette‐G. Ziegler, Åke Lernmark, Jorma Toppari, Jeffrey P. Krischer, Beena Akolkar, Stephen S. Rich, Jin‐Xiong She	44
16	The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report 2017 ·Diabetes ·Jeffrey P. Krischer, Xiang Liu, Åke Lernmark, William Hagopian, Marian Rewers, Jin‐Xiong She, Jorma Toppari, Anette‐G. Ziegler, Beena Akolkar, (unknown)	87
17	Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study 2017 ·Diabetes Care ·Jeffrey P. Krischer, Kristian Lynch, Åke Lernmark, William Hagopian, Marian Rewers, Jin‐Xiong She, Jorma Toppari, Anette‐G. Ziegler, Beena Akolkar, (unknown)	130
18	Factors That Increase Risk of Celiac Disease Autoimmunity After a Gastrointestinal Infection in Early Life 2016 ·Clinical Gastroenterology and Hepatology ·Kaisa Kemppainen, Kristian Lynch, Edwin Liu, Maria Lönnrot, Ville Simell, Thomas Briese, Sibylle Koletzko, William Hagopian, Marian Rewers, Jin‐Xiong She, Olli Simell, Jorma Toppari, Anette‐G. Ziegler, Beena Akolkar, Jeffrey P. Krischer, Åke Lernmark, Heikki Hyöty, Eric W. Triplett, Daniel Agardh	129
19	Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8 ⁺ T Cells in Type 1 Diabetes 2013 ·Science Translational Medicine ·Bart O. Roep, Nanette Solvason, Peter A. Gottlieb, Joana R. F. Abreu, Leonard C. Harrison, George S. Eisenbarth, Liping Yu, Michael Leviten, William Hagopian, John B. Buse, Matthias von Herrath, Joanne Quan, R. S. B. King, William H. Robinson, Paul J. Utz, Hideki Garren, (unknown), (unknown)	127
20	A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM 1994 ·Diabetologia ·C. E. Grubin, T. Daniels, Bert Toivola, Mona Landin‐Olsson, William Hagopian, (unknown), Allan E. Karlsen, Esper Boel, B Michelsen, Åke Lernmark	351

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact